Centessa Pharmaceuticals (CNTA) Short Interest Ratio & Short Volume → [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (From Crypto 101 Media) (Ad) Free CNTA Stock Alerts $8.87 -0.08 (-0.89%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Centessa Pharmaceuticals Short Interest DataCurrent Short Volume1,790,000 sharesPrevious Short Volume1,280,000 sharesChange Vs. Previous Month+39.84%Dollar Volume Sold Short$16.40 millionShort Interest Ratio / Days to Cover5.3Last Record DateApril 30, 2024Outstanding Shares113,040,000 sharesFloat Size59,770,000 sharesShort Percent of Float2.99%Today's Trading Volume65,974 sharesAverage Trading Volume262,642 sharesToday's Volume Vs. Average25% Short Selling Centessa Pharmaceuticals ? Sign up to receive the latest short interest report for Centessa Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCNTA Short Interest Over TimeCNTA Days to Cover Over TimeCNTA Percentage of Float Shorted Over Time Ad True Market Insidersget a piece of the profit from this land This isn’t the prettiest land on earth. But it might be the most valuable. And you don’t have to own, lease, or rent any land.Click here to see my #1 investment for 2024. Centessa Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20241,790,000 shares $16.40 million +39.8%3.0%5.3 $9.16 4/15/20241,280,000 shares $13.80 million -26.4%2.1%3 $10.78 3/31/20241,740,000 shares $19.66 million +13.0%3.1%4.4 $11.30 3/15/20241,540,000 shares $16.56 million No Change2.8%3.9 $10.75 2/29/20241,540,000 shares $16.19 million -3.1%2.8%4.2 $10.51 2/15/20241,590,000 shares $17.22 million +43.2%2.9%4.2 $10.83 Get the Latest News and Ratings for CNTA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Centessa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/20241,110,000 shares $9.09 million -11.2%1.9%4.5 $8.19 1/15/20241,250,000 shares $8.88 million +14.7%2.2%7.4 $7.10 12/31/20231,090,000 shares $8.68 million -42.3%1.9%6.9 $7.96 12/15/20231,890,000 shares $13.44 million +11.2%3.2%12.8 $7.11 11/30/20231,700,000 shares $10.20 million +11.1%2.9%12.2 $6.00 11/15/20231,530,000 shares $11.03 million +15.0%2.6%14 $7.21 10/31/20231,330,000 shares $8.74 million -2.9%2.3%11.9 $6.57 10/15/20231,370,000 shares $8.23 million +1.5%2.4%11.2 $6.01 9/30/20231,350,000 shares $8.73 million +0.8%2.3%9.4 $6.47 9/15/20231,340,000 shares $9.33 million +3.1%2.3%9.2 $6.96 8/31/20231,300,000 shares $9.80 million -29.7%2.3%8 $7.54 8/15/20231,850,000 shares $12.78 million -0.5%3.2%10.9 $6.91 7/31/20231,860,000 shares $14.69 million +2.2%3.3%10.1 $7.90 7/15/20231,820,000 shares $13.78 million +1.1%3.3%13 $7.57 6/30/20231,800,000 shares $11.14 million +2.9%3.9%11.7 $6.19 6/15/20231,750,000 shares $9.52 million -1.7%3.8%11 $5.44 5/31/20231,780,000 shares $8.03 million +4.7%3.9%12 $4.51 5/15/20231,700,000 shares $7.89 million -2.3%3.7%9.4 $4.64 4/30/20231,740,000 shares $8.21 million No Change3.8%10.7 $4.72 4/15/20231,740,000 shares $6.99 million -10.3%3.8%9.2 $4.02 3/31/20231,940,000 shares $7.47 million +6.6%4.3%10.9 $3.85 3/15/20231,820,000 shares $7.04 million -1.1%4.0%11.3 $3.87 2/28/20231,840,000 shares $6.48 million +1.7%4.1%12.4 $3.52 2/15/20231,810,000 shares $5.72 million -0.6%4.0%13.5 $3.16 1/31/20231,820,000 shares $7.28 million +0.6%4.0%16 $4.00 1/15/20231,810,000 shares $6.70 million +2.3%4.0%15.7 $3.70 12/30/20221,770,000 shares $5.49 million -4.8%3.9%16.7 $3.10 12/15/20221,860,000 shares $6.55 million -8.8%4.1%16.4 $3.52 11/30/20222,040,000 shares $8.16 million -5.6%4.5%14.8 $4.00 11/15/20222,160,000 shares $7.62 million -3.1%4.8%12.7 $3.53 10/31/20222,230,000 shares $8.85 million +4.7%5.0%12.9 $3.97 10/15/20222,130,000 shares $8.54 million +3.9%4.7%11.8 $4.01 9/30/20222,050,000 shares $8.24 million -22.9%4.6%12.4 $4.02 9/15/20222,660,000 shares $12.64 million -6.3%5.9%17.1 $4.75[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (Ad)Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. CNTA Short Interest - Frequently Asked Questions What is Centessa Pharmaceuticals' current short interest? Short interest is the volume of Centessa Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 1,790,000 shares of CNTA short. 2.99% of Centessa Pharmaceuticals' shares are currently sold short. Learn More on Centessa Pharmaceuticals' current short interest. What is a good short interest ratio for Centessa Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CNTA shares currently have a short interest ratio of 5.0. Learn More on Centessa Pharmaceuticals's short interest ratio. Which institutional investors are shorting Centessa Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Centessa Pharmaceuticals: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Centessa Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.99% of Centessa Pharmaceuticals' floating shares are currently sold short. Is Centessa Pharmaceuticals' short interest increasing or decreasing? Centessa Pharmaceuticals saw a increase in short interest in April. As of April 30th, there was short interest totaling 1,790,000 shares, an increase of 39.8% from the previous total of 1,280,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Centessa Pharmaceuticals' float size? Centessa Pharmaceuticals currently has issued a total of 113,040,000 shares. Some of Centessa Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Centessa Pharmaceuticals currently has a public float of 59,770,000 shares. How does Centessa Pharmaceuticals' short interest compare to its competitors? 2.99% of Centessa Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Centessa Pharmaceuticals: OPKO Health, Inc. (26.42%), 89bio, Inc. (10.93%), Liquidia Co. (10.62%), Ocular Therapeutix, Inc. (13.61%), Immunome, Inc. (4.42%), Arcutis Biotherapeutics, Inc. (18.74%), ABIVAX Société Anonyme (0.12%), ARS Pharmaceuticals, Inc. (15.81%), Bicycle Therapeutics plc (6.52%), Pliant Therapeutics, Inc. (12.51%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Centessa Pharmaceuticals stock? Short selling CNTA is an investing strategy that aims to generate trading profit from Centessa Pharmaceuticals as its price is falling. CNTA shares are trading down $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Centessa Pharmaceuticals? A short squeeze for Centessa Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CNTA, which in turn drives the price of the stock up even further. How often is Centessa Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CNTA, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: OPK Short Interest Data ETNB Short Interest Data LQDA Short Interest Data OCUL Short Interest Data IMNM Short Interest Data ARQT Short Interest Data ABVX Short Interest Data SPRY Short Interest Data BCYC Short Interest Data PLRX Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CNTA) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingDems have chosen Biden replacement?Paradigm PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaA letter is coming from the "Bureau of the Fiscal Service".Stansberry ResearchCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceBill Clinton Backing Biden Replacement???The Freeport SocietyForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the Markets4 Cryptos BETTER than BitcoinTrue Market Insiders